Farmer estimation of live bodyweight of cattle: implications for veterinary drug dosing in East Africa.

Prev Vet Med

Centre for Tropical Veterinary Medicine, University of Edinburgh, Royal (Dick) School of Veterinary Studies, Easter Bush, Roslin, Midlothian, Edinburgh EH25 9RG, UK.

Published: November 2008

The ability of smallholder farmers and animal health workers to estimate live bodyweight can critically affect the likelihood of under- or over-dosing of veterinary compounds in decentralised systems where farmers administer a significant proportion of the veterinary treatments. A survey of 324 cattle owned by 170 farmers was conducted in Busia District, Kenya. Cattle were weighed on a standard calibrated scale and owners were asked to estimate the live weight of their animals. Weights were also estimated by a weigh-band and by local animal health workers. Cattle owners consistently underestimated the weights of their cattle; 85.7% of the cattle had their bodyweights underestimated by an average of 46.9% of their true weight. Furthermore, very few cattle (19.0%) had their weights estimated accurately to within +/-20% of their true weight by these farmers, an accuracy range important for drug dosing. This finding raises concerns of widespread under-dosing of cattle with trypanocidal and other veterinary drugs. Animal health workers were better at estimating live bodyweight of cattle; 76.6% of cattle were estimated accurately to within +/-20% of their true weight. It is possible to improve farmers' and animal health workers' ability to estimate accurately live bodyweight of cattle with appropriate training. Evidence of this was provided by animal health workers whose estimates improved over time as they received feedback of the true weights of different sizes of cattle from the standard scale.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prevetmed.2008.06.001DOI Listing

Publication Analysis

Top Keywords

animal health
20
live bodyweight
16
health workers
16
cattle
12
bodyweight cattle
12
true weight
12
drug dosing
8
estimate live
8
weights estimated
8
estimated accurately
8

Similar Publications

Genomic data on from the African continent are currently lacking, resulting in the region being under-represented in global analyses of infection (CDI) epidemiology. For the first time in Nigeria, we utilized whole-genome sequencing and phylogenetic tools to compare isolates from diarrhoeic human patients (=142), livestock (=38), poultry manure (=5) and dogs (=9) in the same geographic area (Makurdi, north-central Nigeria) and relate them to the global population. In addition, selected isolates were tested for antimicrobial susceptibility (=33) and characterized by PCR ribotyping (=53).

View Article and Find Full Text PDF

Background: In an Italian cohort of lupus podocytopathy patients, we aimed to characterize the presenting features, therapy, and outcomes, and explore differences between relapsing and non-relapsing patients.

Methods: We identified 29 patients with lupus podocytopathy from 1994 to 2023 in 11 Italian Nephrology/Rheumatology Units, and divided them into two groups: relapsing and non-relapsing. Given the limited sample size, a p-value ≤ 0.

View Article and Find Full Text PDF

Therapeutic gene correction of HBB frameshift CD41-42 (-TCTT) deletion in human hematopoietic stem cells.

Adv Biotechnol (Singap)

January 2025

MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, Guangdong, China.

Β-thalassemia is one of the global health burdens. The CD41-42 (-TCTT) mutation at HBB is the most prevalent pathogenic mutation of β-thalassemia in both China and Southeast Asia. Previous studies focused on repairing the HBB CD41-42 (-TCTT) mutation in β-thalassemia patient-specific induced pluripotent stem cells, which were subsequently differentiated into hematopoietic stem and progenitor cells (HSPCs) for transplantation.

View Article and Find Full Text PDF

Cancers of the brain and central nervous system: global patterns and trends in incidence.

J Neurooncol

January 2025

Cancer Surveillance Branch, International Agency for Research On Cancer (IARC), 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, Lyon, France.

Background: Global comparisons of the burden and impact of cancers of the brain and central nervous system (CNS) are critical for developing effective control strategies and generating etiological hypotheses to drive future research.

Methods: National incidence estimates were obtained from GLOBOCAN 2022, and recorded incidence data from the Cancer in Five Continents series, both developed and compiled by the International Agency for Research on Cancer. We examined the estimated age-standardized incidence rates in 185 countries, as well as time trends in recorded incidence in 35 countries, quantifying the direction and change in the magnitude of the rates using the estimated average percentage change (EAPC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!